Skip to main content

Table 2 Patterns of management according to stroke mechanism. INDIA study-French Guiana

From: The epidemiology and management of stroke in French Guiana

CharacteristicsAll patients
N = 298 (%)
Ischemic stroke
N = 234 [78.5%] (%)
Intra-cerebral hemorrhage
N = 64 [21.4%] (%)
Thrombolysis*32 (10.7)32 (13.6)0
During in-hospital stay
Medical treatment
 Antiplatelet therapy ± *181 (60.9)181 (77.6)0
 Antihypertensive drug ±76 (25.8)61 (26.5)15 (23.4)
 Heparin ±129 (43.8)122 (53)7 (10.9)
 Injectable nicardipine ±98 (33.2)55 (23.8)43 (67.1)
 Insulin ±42 (14.1)38 (16.3)4 (6.20)
 Oral anti diabetics ±16 (5.4)16 (6.9)0
 Urinary catheter35 (11.7)19 (8.1)16 (25)
Other examinations
 CT scanner253 (84.9)193 (82.4)60 (93.7)
 MRI179 (6)152 (64.9)27 (42.1)
 Ultrasonography of the supra-aortic arteries145 (48.6)138 (58.9)7 (10.9)
 Angio-scanner169 (56.7)139 (59.4)30 (46.8)
 ECG±294 (98.9)233 (99.5)61 (96.8)
 Holter±113 (38.1)110 (47.2)3 (4.7)
 Trans-oesophageal ultrasonography17 (5.7)17 (7.2)0
 Trans-thoracic echocardiography±225 (75.7)190 (81.2)35 (55.5)
 MRI as first radiological examination110 (36.9)92 (39.3)18 (28.1)
 Had both MRI and scanner135 (45.3)112 (47.9)23 (35.9)
After discharge
Medical treatment
 Antiplatelet therapy±197 (72.1)196 (87.8)1 (2)
 Anticoagulant therapy±62 (22.7)51 (22.8)11 (22)
 Antihypertensive drug±226 (82.7)182 (81.6)44 (88)
 Statin±187 (68.5)180 (80.7)7 (14)
Non-medical treatment
 Speech therapy±42 (15.9)33 (12.5)9 (18.7)
 Physical therapy±136 (51.5)106 (49.3)30 (61.2)
Care pathways– admitted in …
 UNV1  
 Neurology±181 (61.3)144 (62)37 (58.7)
 Short stay unit (UHCD)±177 (60)135 (45.7)42 (66.6)
 ICU±11 (3.7)2 (0.86)9 (14.2)
 Medecine±65 (22)53 (22.8)12 (19)
 Otherunits±43 (14.5)37 (15.9)6 (9.5)
Follow up checkup programmed ±188 (73.4)152 (73)36 (75)
Follow up checkup done at hospital139 (50.3)109 (48.6)30 (57.6)
Follow up checkup done: Examinations done after discharge
 MIR33 (23.70)19 (17.40)14 (46.60)
 Arteriography3 (2.10)2 (1.80)1 (0.72)
 Trans-esophagealultrasonography10 (7.10)10 (9.10)0
 Transthoracicultrasonography4 (2.80)4 (3.60)0
 Holter±12 (8.70)11 (10.10)1 (3.30)
  1. ± Missing values:
  2. ∙ During care: Antiplatelet therapy = 1; Antihypertensive drug = 4; Heparin = 4; Injectable nicardipine = 3; Insulin = 1; Oral anti diabetics = 2; ECG = 1; Holter = 2; Trans-thoracic echocardiography = 1
  3. ∙ At discharge: Antiplatelet therapy = 25; Anticoagulant therapy = 25; Antihypertensive drug = 25; Statin = 25; Speech therapy = 34; Physical therapy = 34
  4. ∙ Care pathway: Neurology = 3; Short Stay Unit = 3; ICU = 3; Medicine = 3; other = 3; Follow up check-up programmed = 42; Follow up check-up done = 22
  5. ∙ Follow up checkupdone: Holter = 1
  6. *significant p value